An Examination of Whether Infrared Light Therapy Can Reduce Stress in People With Epilepsy
PBM Rise
Photobiomodulation Radiant Intervention for Stress in Epilepsy
1 other identifier
interventional
80
1 country
4
Brief Summary
Do you have Epilepsy? Would you like to participate in a study using PhotoBioModulation (PBM)? PBM is being researched for potential benefits in resolving many stress-related brain disorders. It is a non-invasive technique that delivers light energy to cells and tissues that can promote brain stabilization and self-regulation, cell repair, reduce oxidative stress, and enhance cellular function. We ask you to participate for about 3-4 months and come to our facility for 30 minute sessions 3x a week for 15 weeks. You will receive extensive metabolic testing and an Õura ring for your participation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 11, 2025
CompletedFirst Submitted
Initial submission to the registry
March 25, 2026
CompletedFirst Posted
Study publicly available on registry
April 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 11, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 11, 2027
April 23, 2026
April 1, 2026
1 year
March 25, 2026
April 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective level of stress
This study will look at how perceived stress can be moderated with 45 20-minute photobiomodulation sessions and how this affects seizure duration, intensity, and frequency in people with epilepsy, with the Perceived Stress Scale (PSS), and a post score 20% improved from the pre-test score.
Start to post-intervention to 6-month follow-up
Study Arms (2)
Active photobiomodulation sessions
ACTIVE COMPARATORParticipants will undergo 45 20-minute sessions of photobiomodulation. All other aspects of the study will be the same as the sham group. The Vielight Pro 2 PBM system we'll be using for this study emits pulsed 810nm near infra-red light through the nasal passage and cranium. It is a helmet that is placed on the head, and a light emitter is clipped onto the nostril. The participant will sit comfortably in a dimly-lit room, allow the helmet to be placed on their head and clip to be placed on the nostril (see below). The sessions last 20 minutes. They can read, listen to music, write, or draw during the session.
Control photobiomodulation sessions
SHAM COMPARATOROne third of the participants will undergo 45 20-minute 'fake' photobiomodulation sessions. All other aspects of the study will be the same as the active group.
Interventions
Transcranial photobiomodulation emits low light (infrared) through the scalp and energizes mitochondria, which in turn produce more energy. It is assumed that many brain-related disorders are afflicted with this phenomenon.
Eligibility Criteria
You may qualify if:
- \>18 YO
- Epilepsy - medical diagnosis with at least one seizure within the past 6 months: diagnosis to be obtained from medical records from the treating physician by signature of HIPAA-compliant medical release form
- Agreement to maintain or reduce medication regimen (based upon prescribers' advice)
- Available for intake, baseline, post-treatment, 6-month follow-up assessments, and 45 sessions of PBM
- Willingness to wear an Õura ring at all times (except for charging) for the duration of the study.
You may not qualify if:
- \< 17 YO
- Substance use
- Personality disorders
- Heavy metal toxicity
- Mold toxicity
- Metabolic measures thresholded based on participant type
- Increase in current medication (dosage and/or type)
- No new medications prescribed (reduction as prescribed by prescribing physician OK)
- Current brain bleed
- Acute TBI within the last 12 months
- History of neuromodulation, including ECT
- Brain implants/pumps/shunts
- History of brain surgery
- Hormone replacement therapy for menopause or gender transition
- Untreated sleep disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cynthia Kersonlead
Study Sites (4)
Brain Health Center Miami
North Miami, Florida, 33162, United States
Right Mind Wellness Center
Cincinnati, Ohio, 45227, United States
Holly Maggiano, MD
Warren, Ohio, 44484, United States
Houston Neuroscience Brain Center
Houston, Texas, 77098, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cynthia Kerson, PhD
Saybrook University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Statistical analyzer
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Professor, Principal Investigator
Study Record Dates
First Submitted
March 25, 2026
First Posted
April 3, 2026
Study Start
August 11, 2025
Primary Completion (Estimated)
August 11, 2026
Study Completion (Estimated)
August 11, 2027
Last Updated
April 23, 2026
Record last verified: 2026-04